Code(Target)Commerical RightsIndicationStudy AreaStagePartnersEOC103(HDAC)China and Certain Other Asian CountriesBreast Cancer(Exe. Combo)Breast Cancer(Ful. Combo)ChinaChinaPhase III Phase II EOC202(Lag3-IgG Fc)Greater ChinaBreast CancerEUChinaPhase IIPhase I completed
Does anyone know the status of EOC Pharma Phase II study or generally ? Last update I can find is ANN April 2020
Ann: Immutep to present AIPAC Overall Survival data at SABCS 2020, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.010(3.57%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 27.5¢ | $814.3K | 2.871M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 186340 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 136417 | 6 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |